Displaying 1 - 11 of 11
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View